Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mannose-binding lectin: biology and clinical implications.

D L Worthley1, P G Bardy, C G Mullighan

  • 1Department of Gastroenterology, Flinders Medical Centre, South Australia, Australia.

Internal Medicine Journal
|August 18, 2005
PubMed
Summary

Mannose-binding lectin (MBL) is a key innate immune molecule. MBL replacement therapy shows promise for preventing infections in individuals with MBL deficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

bioRxiv : the preprint server for biology·2026
Same author

Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.

Leukemia·2024
Same author

Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell Transplantation.

HLA·2018
Same author

Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.

Leukemia·2017
Same author

A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm.

Scientific reports·2017
Same author

Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.

Clinical pharmacology and therapeutics·2017

Area of Science:

  • Immunology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Mannose-binding lectin (MBL) is a crucial innate immune molecule recognizing pathogens and activating complement.
  • MBL's structure involves multimeric aggregation of triple-helical peptides.
  • The MBL2 gene harbors polymorphisms affecting MBL levels and function.

Purpose of the Study:

  • To review MBL biology and its association with various diseases.
  • To explore the therapeutic potential of MBL replacement therapy for infection prevention.

Main Methods:

  • Literature review of MBL biology, genetics, and clinical associations.
  • Analysis of MBL2 gene polymorphisms and their impact on MBL levels.
  • Examination of MBL deficiency-associated infections and MBL replacement strategies.

Related Experiment Videos

Main Results:

  • Common MBL2 polymorphisms lead to reduced MBL levels in a significant portion of the population.
  • Low MBL levels are linked to increased susceptibility and severity of infections, especially in immunocompromised individuals.
  • MBL replacement therapy is a potential strategy for managing infections in MBL-deficient patients.

Conclusions:

  • MBL plays a vital role in innate immunity.
  • MBL deficiency increases infection risk, particularly in vulnerable populations.
  • Therapeutic administration of MBL offers a promising approach for passive immunotherapy against infections.